Teva Migraine Drug Wins FDA Approval | Fortune
Teva Pharmaceutical Industries Ltd. won U.S. regulatory approval to sell a new treatment for migraines, a key part of the company’s turnaround strategy. The stock surged in after-hours trading.
weiterlesen